Furthermore, this drug could downregulate LCN2 expression in esophageal cancer cells and increase the accumulation of intracellular ROS levels to activate the ER stress response, resulting in a significant increase in autophagy, followed by tumor cell death. The gene discussed is LCN2; the disease is neoplasm.